Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI.
D000818:Animals; D000906:Antibodies / Q000276:immunology*; D015703:Antigens, CD / Q000276:immunology; D001782:Blood Donors; D017252:CD3 Complex / Q000276:immunology*; D002454:Cell Differentiation; D002465:Cell Movement; D002478:Cells, Cultured; D018925:Chemokines / Q000378:metabolism; D003713:Dendritic Cells / Q000276:immunology*; D015536:Down-Regulation; D006086:Graft vs Host Disease / Q000276:immunology*; D018380:Hematopoietic Stem Cell Transplantation; D039001:Integrin alpha Chains / Q000276:immunology; D007938:Leukemia / Q000276:immunology* / Q000473:pathology / Q000601:surgery; D051379:Mice; D019707:Receptors, Chemokine / Q000276:immunology; D013601:T-Lymphocytes / Q000166:cytology* / Q000276:immunology* / Q000378:metabolism; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D015854:Up-Regulation; D014916:Whole-Body Irradiation
D000906:Antibodies; D015703:Antigens, CD; D017252:CD3 Complex; D018925:Chemokines; D039001:Integrin alpha Chains; D019707:Receptors, Chemokine; C091367:alpha E integrins